VACCINEX INC (VCNX:OTCMKTS)
$0.75 0 (0%)
Analysed VACCINEX INC (VCNX:OTCMKTS) News Sources
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
23-12-2025
yahoo.com
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08-07-2026
yahoo.com
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
07-10-2026
yahoo.com
What is the current price of VACCINEX INC (VCNX:OTCMKTS)?
The current price of VACCINEX INC (VCNX:OTCMKTS) is $0.75.
VACCINEX INC (VCNX:OTCMKTS) absolute price change since previous trading day?
The absolute price change of VACCINEX INC (VCNX:OTCMKTS) since the previous trading day is $0.
VACCINEX INC (VCNX:OTCMKTS) percentage price change since previous trading day?
The percentage price change of VACCINEX INC (VCNX:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for VACCINEX INC (VCNX:OTCMKTS)?
The most recent average sentiment score for VACCINEX INC (VCNX:OTCMKTS) is 80 out of 100.
What is the most recent average sentiment for VACCINEX INC (VCNX:OTCMKTS)?
The most recent sentiment for VACCINEX INC (VCNX:OTCMKTS) is .
SEC-8K** Filing Available For VACCINEX INC (VCNX:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.